A customer reported that an (b)(6) year old male patient underwent a severe trauma cranioencephalic procedure on (b)(6) 2020.When the surgeon and assistant opened the 202010ds 5ml duraseal single kit per box, they found that the quantity sealant of the syringe only had half.The product was in contact with the patient with no patient injury.There was a delay in surgery with no specific time given.The procedure was not delayed, the device was requested intraoperatively.No medical revision or intervention needed.
|
Integra has performed a thorough review of the reported incident.There was no product received back, as such only a dhr review could be performed.At the time of manufacturing, records from each manufacturing lot are thoroughly reviewed to ensure that products are released meeting all quality release specifications.With the information provided a root cause could not be reliably determined.There currently is a corrective action plan open at the manufacturing vendor site, to address syringes being half filled.Different activities have been implemented in the production floor to mitigate this failure mode reported.Post market vigilance will continue to monitor this condition for future potential action.Should new information become available, the file will be re-opened and the investigation will be amended as appropriate.
|